Market Tracker

04/17 6:02pm ET

Galectin Therapeutics Inc (NASDAQ:GALT)

3.36
Delayed Data
As of Apr 17
 -0.07 / -2.04%
Today’s Change
3.00
Today|||52-Week Range
16.55
-3.17%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close3.43
Today’s open3.38
Day’s range3.34 - 3.47
Volume64,230
Average volume (3 months)125,866
Market cap$81.0M
Dividend yield--
Data as of 4:00pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+40.00%
Earnings growth (this year)+2.56%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.70

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc+0.28+2.73%
GBIMGlobeImmune Inc-0.72-7.70%
GBSNUGreat Basin Scientif...+0.60+4.44%
TROVUTrovagene Inc0.000.00%
Data as of 4:00pm ET, 04/17/2015

Financials

Next reporting dateMay 15, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$0.00
Annual profit (last year)-$16.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts